Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Merck & Co., Inc. | 34,944.942 | reported | 29 May 2026 | tx 12+28,686.62 |
| CANCER GENETICS, INC | 5,000 | reported | 22 May 2014 | tx 2+15,000 |
| LABCORP HOLDINGS INC. | 773 | reported | 11 Feb 2026 | tx 10+5,774−2,558 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 1,853.1 | 118.72 USD | deriv |
| 11 Feb 2026 | EXERCISE | LABCORP HOLDINGS INC. | 897 | — | |
| 11 Feb 2026 | EXERCISE | LABCORP HOLDINGS INC. | 897 | 0.00 USD | deriv |
| 10 Feb 2026 | GRANT_AWARD | LABCORP HOLDINGS INC. | 733 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Merck & Co., Inc. | 2,863.09 | 76.84 USD | deriv |
| 11 Feb 2025 | GRANT_AWARD | LABCORP HOLDINGS INC. | 897 | 0.00 USD | deriv |
| 06 Feb 2025 | EXERCISE | LABCORP HOLDINGS INC. | 944 | — | |
| 06 Feb 2025 | EXERCISE | LABCORP HOLDINGS INC. | 944 | 0.00 USD | deriv |
| 06 Jun 2024 | EXERCISE | LABCORP HOLDINGS INC. | 717 | — | |
| 06 Jun 2024 | EXERCISE | LABCORP HOLDINGS INC. | 717 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | Merck & Co., Inc. | 1,752.43 | 125.54 USD | deriv |
| 06 Feb 2024 | GRANT_AWARD | LABCORP HOLDINGS INC. | 944 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | LABCORP HOLDINGS INC. | 642 | 0.00 USD | deriv |
| 26 May 2023 | GRANT_AWARD | Merck & Co., Inc. | 1,980.73 | 111.07 USD | deriv |
| 27 May 2022 | GRANT_AWARD | Merck & Co., Inc. | 2,363.56 | 93.08 USD | deriv |
| 28 May 2021 | GRANT_AWARD | Merck & Co., Inc. | 2,635.39 | 75.89 USD | deriv |
| 29 May 2020 | GRANT_AWARD | Merck & Co., Inc. | 2,477.7 | 80.72 USD | deriv |
| 31 May 2019 | GRANT_AWARD | Merck & Co., Inc. | 2,335.56 | 79.21 USD | deriv |
| 25 May 2018 | GRANT_AWARD | Merck & Co., Inc. | 3,130.82 | 59.09 USD | deriv |
| 26 May 2017 | GRANT_AWARD | Merck & Co., Inc. | 2,618.61 | 64.92 USD | deriv |
| 27 May 2016 | GRANT_AWARD | Merck & Co., Inc. | 3,009.92 | 56.48 USD | deriv |
| 01 Sept 2015 | GRANT_AWARD | Merck & Co., Inc. | 1,665.71 | 52.53 USD | deriv |
| 22 May 2014 | GRANT_AWARD | CANCER GENETICS, INC | 5,000 | 0.00 USD | |
| 22 May 2014 | GRANT_AWARD | CANCER GENETICS, INC | 10,000 | 0.00 USD | deriv |